Initiatives rely on artificial intelligence to diagnose autism in children, diagnose dementia, and use Assistive Technology and Augmentative Communication Devices.

 Emirates Health Services (EHS) announced a series of ground-breaking artificial intelligence (AI) based projects on day two of Arab Health 2022, where EHS is participating under the slogan “A Renewed Vision for the Health of the Emirates”.

The new launches include new techniques for “Diagnosing Autism in Children Using Artificial Intelligence”, “Diagnosing Dementia Using Artificial Intelligence”, and “Using Assistive Technology and Augmentative Communication Devices”. The projects will be presented to visitors at the EHS booth at the exhibition, where it has one of the largest platforms of the event with four different sections, namely, A Healthy Community, Wellbeing, Innovative Treatment Services, and Digital Health.

Dr. Noor Al Muhairi, Director of the Mental Health Department at Emirates Health Services, said: “Emirates Health Services is committed to keeping up with the times and adapting to the rapid developments of our era, where individual preferences and requirements are becoming more complex and the public’s appetite for services based on digital reality, artificial intelligence, and 3D services is growing. With that in mind, EHS is channelling its efforts towards strengthening its health ecosystem, launching innovative projects to enhance smart services and maintain the UAE’s regional and global lead on performance indicators”.

Emirates Health Services showcased the “Diagnosing Autism in Children Using Artificial Intelligence” project, in partnership with the Children’s Hospital of Philadelphia (CHOP) Centre for Autism Research – the latter had developed the Sensor Tree as a diagnostic, educational, and research tool. The biosensor captures everything participants say and do with perfect synchronisation with up to 90% accuracy to detect whether a participant has autism.

EHS also introduced participants at the exhibition to the “Diagnosing Dementia Using Artificial Intelligence” project – an Integrated Cognitive Assessment Technology, CE marked, MHRA registered, and FDA Class II medical device. The project consists of a five-minute, software-based, computerised cognitive assessment tool; it uses (AI) to compare ICA tests previously taken by both healthy and cognitively impaired individuals. This enables the ICA to provide an objective measurement of cognitive performance.

Last but not least, EHS unveiled the “Using Assistive Technology and Augmentative Communication Devices” project, designed in partnership with Maudsley Health. With Assistive Technology and integrated software and hardware Augmentative and Alternative Communication (“AAC”), the project offers solutions for people who suffer from various medical conditions adversely affecting their ability to speak (e.g. aphasia, autism, Parkinson’s disease, Cerebral Palsy, spinal cord injuries, and others).